The CEO of AZ is in Sydney where he has been for over a year. The french man has been copping flack from internals for the pricing of his product compared to Pfizers CEO. The AZ was done at near to cost, or as close as you could get, but Pfizers was done with what I heard was $36 billion coming into their back accounts. There's a few dollars there for future Pfizer blockbusters.
